BioLineRx (BLRX) Shares Outstanding (Entity) (2017 - 2025)
BioLineRx (BLRX) Shares Outstanding (Entity) (2017 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 139.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.54 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 214.24 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 113.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 575.47 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.73 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 218.28 Mn |
| 10 | BioLineRx | 7.21 Bn | 7.21 Bn | 154,000.00 | 2.61 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.08 Bn |
| Sep 30, 2025 | 3.26 Bn |
| Jun 30, 2025 | 2.96 Bn |
| Mar 31, 2025 | 2.77 Bn |
| Dec 31, 2024 | 1.50 Bn |
| Sep 30, 2024 | 59.97 Bn |
| Jun 30, 2024 | 59.88 Bn |
| Mar 31, 2024 | 39.51 Bn |
| Dec 31, 2023 | 35.03 Bn |
| Sep 30, 2023 | 33.78 Bn |
| Jun 30, 2023 | 33.56 Bn |
| Mar 31, 2023 | 33.56 Bn |
| Dec 31, 2022 | 28.14 Bn |
| Sep 30, 2022 | 26.94 Bn |
| Jun 30, 2022 | 26.01 Bn |
| Mar 31, 2022 | 26.01 Bn |
| Dec 31, 2021 | 24.11 Bn |
| Sep 30, 2021 | 25.76 Bn |
| Jun 30, 2021 | 24.33 Bn |
| Mar 31, 2021 | 20.35 Bn |